Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.

Clinica chimica acta; international journal of clinical chemistry - 1 Feb 2020

Zheng Hong, Dong Baijun, Ning Jie, Shao Xiaoguang, Zhao Liangcai, Jiang Qiaoying, Ji Hui, Cai Aimin, Xue Wei, Gao Hongchang

Abstract excerpt

BACKGROUND: Prostate cancer (PCa) is one of the most common cancers in men, but its metabolic characteristics during tumor progression are still far from being fully understood. METHODS: The metabolic profiles of matched tissue, serum and urine samples from the same patients were analyzed using a 1H NMR-based metabolomics approach. We identified several important metabolites that significantly altered at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Laboratory Techniques

Share to Metabolomics

Share to Nuclear Magnetic Resonance, Biomolecular

Share to Phenotype

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 31758937
DOI: 10.1016/j.cca.2019.10.046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.PMID 31758937Read ↗

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?Semantic proximity Read ↗

Cellular Signaling of Amino Acid Metabolism in Prostate CancerSemantic proximity Read ↗

Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.Semantic proximity Read ↗

Metabolic deregulation in prostate cancerSemantic proximity Read ↗

Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder CancerSemantic proximity Read ↗

Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discoverySemantic proximity Read ↗

Prognostic Significance of Amino Acid Metabolism-Related Genes in Prostate Cancer Retrieved by Machine LearningSemantic proximity Read ↗

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progressionSemantic proximity Read ↗

Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cellsSemantic proximity Read ↗

Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk ModelSemantic proximity Read ↗

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder CancerSemantic proximity Read ↗

Single-cell analysis revealing the metabolic landscape of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.